Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IPRU, .0019/.0021, starting to see some buying.
The trading of IMDS stock has nothing to do with the CTLM itself. It's all about converted debt.
Dirty games being played on both sides here for the rights to the CTLM!
Double bottom forming on the chart??
Yeah.....Right, lol.
139 mil dumped at .0002.
IPRU pulling back again today, .0014/.0015
In case anyone didn't know, IMDS was former NASDAQ trading above $6/share in 2000 before the ex-CEO's death.
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED
STOCKHOLDER MATTERS
The Company's common stock, no par value, is traded on the over-the-counter bulletin board market. The Company's preferred stock is not traded. There has been trading in the Company's common stock since September 20, 1994. The symbol for the Company's common stock is IMDS.
NASDAQ LISTING
On July 21, 1999, we received an opinion of the U.S. Securities and Exchange Commission (the "Commission") dismissing our application for review of our appeal to the denial of our application for Nasdaq Small Cap Market listing. The Commission found that Nasdaq did not exceed its authority by requiring us to (i) satisfy the $4.00 per share bid price requirement; (ii) satisfy all other requirements for initial listing; and (iii) evidence a minimum of $5,000,000 in net tangible assets. The Commission went on to say that the specific grounds identified as the basis for Nasdaq imposing the conditions for inclusion (i.e. the our stock price was well below the $4.00 minimum required for Nasdaq inclusion and concern that we would not be able to maintain compliance with the $2,000,000 net tangible assets maintenance requirement over the long term) existed in fact and therefore Nasdaq did not exceed its authority by requiring the net tangible assets and share bid price conditions. We do not intend to take any further action in this matter.
ALL of these "unsubstantiated positive hype" has been backed by links to filings and relevant material
There will never be an R/S, all anyone has to do is call the company and talk to Linda Grable
Only a matter of time when this round of dilution is over that the company announces their financing, which will be of the non-toxic long term type as stipulated in their 10Q.
So, it is dilution, which may ultimately end up in an RS.
Devcool Member Profile
Friday, June 15, 2012 2:42:59 PM
Re: stockmasterflash post# 8973
Post # of 27900
Ummmm no...that's called accumulation. And the CMF and A/D indicators acknowledge that on the chart Dilution is when we see the stock price continually drop...and to dilute further companies undergo Reverse splits
I am hoping to pick up some 3s tomorrow before she breaks lose
First of five machines purchased by Mexico installed!
In the meantime sales are coming in and more awareness every day.
There is NEVER going to be an R/S on this company stock as there never has been in its history, and I'm looking forward to riding this back to dollarland:
ALL of these "unsubstantiated positive hype" has been backed by links to filings and relevant material
Wow, as usual, where to start. You're wrong on the whole FDA process for IMDS. Don't know where you keep pulling 90 days from. IMDS disagrees with your timeframe. In early filings they had mentioned the De Novo Process, but never did it. Also, the average De Novo review is over a year. Heres a section from their most recent 10Q, pages 56-57.
In previous filings, management had disclosed the potential to have our CTLM® device approved through the FDA “De Novo” process. This process would only become an option to us if the FDA did not approve our 510(k) premarket notification of intent to market the device. While waiting for a ruling from the FDA on our 510(k) premarket notification of intent to market the CTLM®, management continued to research the advantages and disadvantages regarding the potential option to initiate a De Novo application if the FDA determined our traditional 510(k) application to be “Not Substantially Equivalent”. Our research identified several articles illustrating the potential pitfalls of going down the De Novo pathway. One such article from Medical Device Consultants (MDCI), a full service contract research organization and consulting firm that helps emerging and established firms commercialize novel and innovative medical devices, dated March 21, 2011( included below ) best summarizes the issues that we would face if we choose the De Novo pathway.
Understanding that the above statements were a fair representation of the regulatory industry's general feelings towards the FDA De Novo process, management decided to accept and heed the FDA's letter (received on August 2, 2011) detailing their decision of CTLM® being “not substantially equivalent” and furthermore, accepting their recommendation that CTLM® is a class III device that would require a PMA submission. Other considerations such as comparing time frames between De Novo and the PMA process were taken into account. The average De Novo application took 482 days to be reviewed compared to the average PMA review of 284 days. In addition, upon further review, both the De Novo and PMA process require virtually identical clinical safety and efficacy data; therefore, the PMA path was chosen. Management has identified potential FDA regulatory consultants who can guide us through the complete PMA application process and is presently in contract negotiations with several prospective consulting firms.
The ongoing onslaught of unsubstantiated positive hype will not hide the
Inevitable reality of the massive dilution here. AS increase to 10 billion, and cheap shares appear to be flying out the door.
With your repeated headgie claims.....Why would that even happen when Grable has full control through preferred shares. You do realize, one individual could own 95% of the OS, and Grable would still have full control?
There are no hedgies, and most longs are down 40% or more.
Yep, definitely looks bad.
It seems that anything positive regarding imds is immediately attacked like there is no tomorrow!
New shares are being dispersed
Just confirming first of 5 ctlms purchased by mexico
???? They aren't using it, period, lol. There are no new sales. That is just unsubstantiated hype. If there were sales, IMDS would have PRd that instead. You got a PR about a CTLM being installed, that was paid for months ago.
No new sales, sorry.
Mexico has just opened a new state of the art hospital facility and is using and committing to the CTLM
It's closing in on 1 year since the 5 units were announced. One sold, installed months later, and still can't be used, lol.
I figured folks should have the facts. The PR was pump fluff, as I explained in my last post. Unit was paid for months ago, and the installation is huge news, lmao? No it isn't..
No twist of facts. My post was fact, and easily confirmed by looking at the PR and last quarterly.
The Mexico news isn't huge. IMDS PRd this unit sold in November 2011. They were paid 163k for it in the last reported quarter, Jan-Mar 2012. They just PRd it was installed, and rightly so, it was paid for, lol. Problem is, they apparently still can't use it.
They have funding. Have you missed all the added shares in the trade this week? I don't think it's the type of funding they would want to PR, lol.
Well funding news for starters
given the fact that there were far more than 50 million on the bid at .0003.
If I had shares, I would have taken advantage of the .0003s today to.......by dumping to them.
Great, I will have my buy order in for Monday
You'll most likely be correct on Monday's trading during normal hours.
2's up monday.
Wowzer. Maybe they did get new financing, that's even more toxic than the last. There might be some .0001 or .00005 conversions now.
Where's that funding news? It's apparent there has been no change to funding, and also apparent the dilution continues. 10K out any day, and we'll see current OS. I'm thinking close to 5 billion OS now. That would be almost double the 2.4 billion, where many had claimed no dilution since. Then we found out it was 3.8 on August 1st. Oh yeah, and all those old shorts covered.
Devcool Member Profile
Thursday, June 14, 2012 2:49:33 PM
Re: Smilin_B post# 8523
Post # of 27760
$IMDS >> Funding news any day between now and next week, that means there isn't going to be $756,000 worth of converted discounted shares hitting the market.
That means there is no dilution now, and there won't be in the future.
The unknown 3rd party backing the hedge funds sitting at nearly 1.2 billion shares shorted are going to have a wonderful time giving me their wallet.
No, lol. Just playing into the "loading here". No one in their right mind would load IMDS here. The flood of new shares is just starting, lol.